FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation
Abstract Uterine sarcomas are rare but deadly malignancies without effective treatment. Immunotherapy is a promising new approach to treat these tumors but has shown heterogeneous effects in sarcoma patients. With the goal of identifying key factors for improved patient treatment, we characterized t...
Enregistré dans:
Auteurs principaux: | Okan Gultekin, Jordi Gonzalez-Molina, Elin Hardell, Lidia Moyano-Galceran, Nicholas Mitsios, Jan Mulder, Georgia Kokaraki, Anders Isaksson, Dhifaf Sarhan, Kaisa Lehti, Joseph W. Carlson |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/eda4826495d543a98d261183c1886ac9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Radiomics and Artificial Intelligence in Uterine Sarcomas: A Systematic Review
par: Gloria Ravegnini, et autres
Publié: (2021) -
Neoadjuvant chemotherapy for Ewing’s sarcoma family tumors of the uterine cervix: A case report
par: Masahiko Mori, et autres
Publié: (2021) -
Uterine Preservation Treatments in Sarcomas: Oncological Problems and Reproductive Results: A Systematic Review
par: Giulia Dondi, et autres
Publié: (2021) -
Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance
par: Elina A. Pietilä, et autres
Publié: (2021) -
Differentiation of uterine low-grade endometrial stromal sarcoma from rare leiomyoma variants by magnetic resonance imaging
par: Yuki Himoto, et autres
Publié: (2021)